HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

HOOKIPA Pharma Inc. has announced the completion of participant enrollment in a Phase 1b clinical trial for HB-500, a next-generation therapeutic vaccine aimed at treating HIV. The trial ...

The U.S. Centers for Disease Control and Prevention and other federal health agencies on Friday took down webpages with ...

The Phase 1b clinical trial (NCT06430905) is evaluating the safety and tolerability, reactogenicity, and immunogenicity to repeated doses of HB-500 in participants with HIV on suppressive ...

The decision, made by US Secretary of State Marco Rubio, enables individuals in 55 countries, including South Africa, to ...

Real-world analyses have confirmed the efficacy of the 2-drug regimen of dolutegravir and lamivudine in treating HIV, ...

ACACIA Study Is Evaluating Two Long-Acting Broadly Neutralizing Antibodies Given at HIV Treatment InitiationLOS ANGELES, Jan.

Is there an HIV epidemic? There are several factors making the issue of HIV and AIDs among Black folks very concerning.